Name: 2021 Joint Statistical Meetings
Start: 2021-08-08T07:00:00+00:00
End: 2021-08-12

Online Program Home
My Program

All Times EDT

Legend:
* = applied session ! = JSM meeting theme

Activity Details

		Tweet
366 *	Thu, 8/12/2021, 12:00 PM - 1:50 PM		Virtual
Trial Design and Analysis Methods for COVID-19 Treatment/Prevention — Invited Papers
ENAR, Biopharmaceutical Section, Biometrics Section, Caucus for Women in Statistics
Organizer(s): Michael Rosenblum, Johns Hopkins University
Chair(s): Bingkai Wang, Johns Hopkins Bloomberg School of Public Health
12:05 PM	Improving Precision and Power in Randomized Trials for COVID-19 Treatments Using Covariate Adjustment for Binary, Ordinal, or Time-to-Event Outcomes David Benkeser, Emory University; Ivan Diaz, Weill Cornell Medical College; Alex Luedtke, University of Washington; Daniel Scharfstein, University of Utah; Jodi Seagal, Johns Hopkins University; Michael Rosenblum, Johns Hopkins University
12:30 PM	Clinical Trials Impacted by the COVID-19 Pandemic: Adaptive Designs to the Rescue? Cornelia Kunz, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany ; Silke Jörgens, Janssen-Cilag GmbH, Neuss, Germany ; Frank Bretz, Novartis AG; Nigel Stallard, The University of Warwick, Coventry, UK; Kelly Van Lancker, Ghent University, Belgium; Dong Xi, Novartis Pharmaceuticals, East Hanover, New Jersey, USA ; Sarah Zohar, Sorbonne Université, Paris, France; Christoph Gerlinger, Statistics and Data Insights, Bayer AG, Berlin, Germany ; Tim Friede, University Medical Center Göttingen, Göttingen, Germany
12:55 PM	Challenges in clinical trial design during a pandemic: Experiences from the UK and beyond Thomas Jaki, University of Cambridge
1:20 PM	Discussant: Laura Lee Johnson, Center for Drug Evaluation and Research, U.S. FDA
1:40 PM	Floor Discussion

JSM 2021 Online Program

Activity Details

American Statistical Association